Pluri Inc. (PLUR)

Pluri Inc. (PLUR) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $12.5M; returns 1 day -2.0%, 1 week +6.5%, 1 year -74.5%.

Pluri Inc. (PLUR) is an Israeli biotechnology company that has diversified its business beyond traditional cell therapy by leveraging its proprietary, patented 3D cell expansion platform for mass production of cell-based products.

Groups PLUR belongs to

• Israel Companies
• Biotechnology
• Israel
• Contract Development and Manufacturing Organizations (CDMO)
• Life Sciences
• AgTech
• Regenerative Medicine
• Clinical Stage Biotech

PLUR financial model: income statement, cash flow and balance sheet